PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 46 filers reported holding PROQR THRAPEUTICS N V in Q2 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,058 | -44.9% | 420,045 | -31.3% | 0.00% | – |
| Q2 2023 | $990,891 | +35403.1% | 611,661 | -53.3% | 0.00% | -100.0% |
| Q1 2023 | $2,791 | +299.3% | 1,310,406 | +593.6% | 0.00% | – |
| Q4 2022 | $699 | -98.6% | 188,916 | +185.6% | 0.00% | – |
| Q2 2022 | $51,000 | -91.5% | 66,157 | -90.0% | 0.00% | – |
| Q1 2022 | $598,000 | -70.7% | 660,408 | +159.5% | 0.00% | -100.0% |
| Q4 2021 | $2,038,000 | -27.9% | 254,469 | -24.6% | 0.00% | -50.0% |
| Q3 2021 | $2,825,000 | +3345.1% | 337,504 | +2680.1% | 0.00% | – |
| Q2 2021 | $82,000 | -66.3% | 12,140 | -67.0% | 0.00% | – |
| Q1 2021 | $243,000 | -68.2% | 36,837 | -79.7% | 0.00% | -100.0% |
| Q4 2020 | $764,000 | +125.4% | 181,883 | +194.7% | 0.00% | 0.0% |
| Q1 2020 | $339,000 | -90.0% | 61,715 | -82.0% | 0.00% | -75.0% |
| Q4 2019 | $3,401,000 | +165.3% | 343,146 | +54.2% | 0.00% | +100.0% |
| Q3 2019 | $1,282,000 | -55.9% | 222,579 | -30.2% | 0.00% | -50.0% |
| Q2 2019 | $2,904,000 | +13.5% | 319,073 | +73.0% | 0.00% | 0.0% |
| Q1 2019 | $2,559,000 | +79.2% | 184,466 | +103.8% | 0.00% | +100.0% |
| Q4 2018 | $1,428,000 | +0.1% | 90,498 | -53.7% | 0.00% | 0.0% |
| Q2 2018 | $1,426,000 | +870.1% | 195,352 | +563.5% | 0.00% | – |
| Q1 2017 | $147,000 | -80.3% | 29,444 | -80.6% | 0.00% | -100.0% |
| Q4 2016 | $745,000 | -25.2% | 151,974 | +1.8% | 0.00% | 0.0% |
| Q3 2016 | $996,000 | +9.6% | 149,268 | -20.5% | 0.00% | 0.0% |
| Q2 2016 | $909,000 | -60.9% | 187,866 | -60.6% | 0.00% | -66.7% |
| Q1 2016 | $2,324,000 | -69.4% | 476,242 | -45.6% | 0.01% | -62.5% |
| Q4 2015 | $7,593,000 | -35.0% | 874,744 | +9.1% | 0.02% | -30.4% |
| Q3 2015 | $11,678,000 | -6.4% | 801,493 | +7.1% | 0.02% | -4.2% |
| Q2 2015 | $12,478,000 | -22.2% | 748,533 | +2.1% | 0.02% | -20.0% |
| Q1 2015 | $16,042,000 | +252.9% | 733,182 | +249.5% | 0.03% | +200.0% |
| Q4 2014 | $4,546,000 | +74.0% | 209,776 | +38.0% | 0.01% | +42.9% |
| Q3 2014 | $2,613,000 | – | 152,001 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |